Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
EyePoint, Inc.
13G
EYPT · 30233G209
|
9.6% |
10/27/2026
Event 10/20/2026
|
|||
| Tang Capital Management, LLC | 9.6% | ||||
| Kevin Tang | 9.6% | ||||
| Tang Capital Partners, LP | 2.1% | ||||
| Tang Capital Partners International, LP | 3.1% | ||||
| Tang Capital Partners III, Inc | 2.2% | ||||
| Tang Capital Partners IV, Inc | 2.2% | ||||
|
Skye Bioscience, Inc.
13G
SKYE · 83086J309
|
6.0% |
10/14/2026
Event 10/7/2026
|
|||
| Tang Capital Management, LLC | 6.0% | ||||
| Kevin Tang | 6.0% | ||||
| Tang Capital Partners, LP | 1.4% | ||||
| Tang Capital Partners International, LP | 1.8% | ||||
| Tang Capital Partners III, Inc | 1.4% | ||||
| Tang Capital Partners IV, Inc | 1.4% | ||||
|
Atea Pharmaceuticals, Inc.
13G
AVIR · 04683R106
|
6.0% |
10/6/2026
Event 10/6/2026
|
|||
| Tang Capital Management, LLC | 6.0% | ||||
| Kevin Tang | 6.0% | ||||
| Tang Capital Partners, LP | 3.1% | ||||
| Tang Capital Partners International, LP | 2.1% | ||||
| Tang Capital Partners III, Inc | 0.8% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Nano Dimension Ltd.
13G
NNDM · 63008G203
|
9.1% |
8/21/2026
Event 8/19/2026
|
|||
| Tang Capital Management, LLC | 9.1% | ||||
| Kevin Tang | 9.1% | ||||
| Tang Capital Partners, LP | 2.1% | ||||
| Tang Capital Partners International, LP | 2.8% | ||||
| Tang Capital Partners III, Inc | 2.1% | ||||
| Tang Capital Partners IV, Inc | 2.1% | ||||
|
KalVista Pharmaceuticals, Inc.
13G/A
Amendment 5
KALV · 483497103
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Capricor Therapeutics, Inc.
13G/A
Amendment 1
CAPR · 14070B309
|
7.1% |
8/14/2026
Event 6/30/2026
|
|||
| Tang Capital Management, LLC | 7.1% | ||||
| Kevin Tang | 7.1% | ||||
| Tang Capital Partners, LP | 1.6% | ||||
| Tang Capital Partners International, LP | 2.2% | ||||
| Tang Capital Partners III, Inc | 1.5% | ||||
| Tang Capital Partners IV, Inc | 1.8% | ||||
|
Nano Dimension Ltd.
13D/A
Amendment 1
NNDM · 63008G203
|
7.9% |
7/27/2026
Event 7/23/2026
|
|||
| Tang Capital Management, LLC | 7.9% | ||||
| Kevin Tang | 7.9% | ||||
| Tang Capital Partners, LP | 1.8% | ||||
| Tang Capital Partners International, LP | 2.5% | ||||
| Tang Capital Partners III, Inc | 1.8% | ||||
| Tang Capital Partners IV, Inc | 1.8% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Fulcrum Therapeutics, Inc.
13G/A
Amendment 1
FULC · 359616109
|
10.4% |
7/15/2026
Event 7/13/2026
|
|||
| Tang Capital Management, LLC | 10.4% | ||||
| Kevin Tang | 10.4% | ||||
| Tang Capital Partners, LP | 2.5% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 2.5% | ||||
| Tang Capital Partners IV, Inc | 2.2% | ||||
|
Nano Dimension Ltd.
13D
NNDM · 63008G203
|
6.8% |
6/30/2026
Event 6/24/2026
|
|||
| Tang Capital Management, LLC | 6.8% | ||||
| Kevin Tang | 6.8% | ||||
| Tang Capital Partners, LP | 1.6% | ||||
| Tang Capital Partners International, LP | 2.0% | ||||
| Tang Capital Partners III, Inc | 1.6% | ||||
| Tang Capital Partners IV, Inc | 1.6% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Boundless Bio, Inc.
13G
BOLD · 10170A100
|
11.3% |
6/29/2026
Event 6/23/2026
|
|||
| Tang Capital Management, LLC | 11.3% | ||||
| Kevin Tang | 11.3% | ||||
| Tang Capital Partners, LP | 2.6% | ||||
| Tang Capital Partners International, LP | 3.5% | ||||
| Tang Capital Partners III, Inc | 2.6% | ||||
| Tang Capital Partners IV, Inc | 2.6% | ||||
|
Fulcrum Therapeutics, Inc.
13G
FULC · 359616109
|
8.2% |
6/10/2026
Event 6/3/2026
|
|||
| Tang Capital Management, LLC | 8.2% | ||||
| Kevin Tang | 8.2% | ||||
| Tang Capital Partners, LP | 1.9% | ||||
| Tang Capital Partners International, LP | 2.5% | ||||
| Tang Capital Partners III, Inc | 1.9% | ||||
| Tang Capital Partners IV, Inc | 1.9% | ||||
|
Aurinia Pharmaceuticals Inc.
13D/A
Amendment 4
AUPH · 05156V102
|
10.0% |
6/4/2026
Event 6/2/2026
|
|||
| Tang Capital Management, LLC | 10.0% | ||||
| Kevin Tang | 10.0% | ||||
| Tang Capital Partners, LP | 5.6% | ||||
| Tang Capital Partners International, LP | 4.0% | ||||
| Tang Capital Partners III, Inc | 0.2% | ||||
| Tang Capital Partners IV, Inc | 0.2% | ||||
|
Ventyx Biosciences, Inc.
13G/A
Amendment 1
VTYX · 92332V107
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Crescent Biopharma, Inc.
13G/A
Amendment 1
CBIO · G2545C104
|
4.2% |
5/15/2026
Event 3/31/2026
|
|||
| Tang Capital Management, LLC | 4.2% | ||||
| Kevin Tang | 4.2% | ||||
| Tang Capital Partners, LP | 2.2% | ||||
| Tang Capital Partners International, LP | 1.6% | ||||
| Tang Capital Partners III, Inc | 0.3% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Altimmune, Inc.
13G/A
Amendment 3
ALT · 02155H200
|
0.3% |
5/15/2026
Event 3/31/2026
|
|||
| Tang Capital Management, LLC | 0.3% | ||||
| Kevin Tang | 0.3% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0.3% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Kezar Life Sciences, Inc.
13D/A
Amendment 2
KZR · 49372L209
|
0% |
5/13/2026
Event 5/11/2026
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
PureTech Health plc
13G
G7297M101
|
5.2% |
4/29/2026
Event 4/22/2026
|
|||
| Tang Capital Management, LLC | 5.2% | ||||
| Kevin Tang | 5.2% | ||||
| Tang Capital Partners, LP | 2.9% | ||||
| Tang Capital Partners International, LP | 2.0% | ||||
| Tang Capital Partners III, Inc | 0.2% | ||||
| Tang Capital Partners IV, Inc | <0.1% | ||||
|
Kezar Life Sciences, Inc.
13D/A
Amendment 1
KZR · 49372L209
|
9.0% |
4/1/2026
Event 3/30/2026
|
|||
| Tang Capital Management, LLC | 9.0% | ||||
| Kevin Tang | 9.0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 3.7% | ||||
| Tang Capital Partners III, Inc | 5.3% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Aurinia Pharmaceuticals Inc.
13D/A
Amendment 3
AUPH · 05156V102
|
9.2% |
3/25/2026
Event 3/23/2026
|
|||
| Tang Capital Management, LLC | 9.2% | ||||
| Kevin Tang | 9.2% | ||||
| Tang Capital Partners, LP | 5.3% | ||||
| Tang Capital Partners International, LP | 3.9% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Aurinia Pharmaceuticals Inc.
13D/A
Amendment 2
AUPH · 05156V102
|
9.2% |
3/3/2026
Event 2/27/2026
|
|||
| Tang Capital Management, LLC | 9.2% | ||||
| Kevin Tang | 9.2% | ||||
| Tang Capital Partners, LP | 5.3% | ||||
| Tang Capital Partners International, LP | 3.9% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Tarsus Pharmaceuticals, Inc.
13G/A
Amendment 4
TARS · 87650L103
|
2.8% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 2.8% | ||||
| Kevin Tang | 2.8% | ||||
| Tang Capital Partners, LP | 0.8% | ||||
| Tang Capital Partners International, LP | 1.9% | ||||
| Tang Capital Partners III, Inc | 0.1% | ||||
| Tang Capital Partners IV, Inc | <0.1% | ||||
|
Spyre Therapeutics, Inc.
13G/A
Amendment 1
SYRE · 00773J202
|
2.4% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 2.4% | ||||
| Kevin Tang | 2.4% | ||||
| Tang Capital Partners, LP | 1.3% | ||||
| Tang Capital Partners International, LP | 1.1% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Precision BioSciences, Inc.
13G/A
Amendment 3
DTIL · 74019P207
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Nkarta, Inc.
13G/A
Amendment 2
NKTX · 65487U108
|
2.1% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 2.1% | ||||
| Kevin Tang | 2.1% | ||||
| Tang Capital Partners, LP | 0.8% | ||||
| Tang Capital Partners International, LP | 1.3% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Keros Therapeutics, Inc.
13G/A
Amendment 1
KROS · 492327101
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Evolus, Inc.
13G/A
Amendment 4
EOLS · 30052C107
|
1.9% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 1.9% | ||||
| Kevin Tang | 1.9% | ||||
| Tang Capital Partners, LP | 1.0% | ||||
| Tang Capital Partners International, LP | 0.8% | ||||
| Tang Capital Partners III, Inc | 0.1% | ||||
| Tang Capital Partners IV, Inc | <0.1% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 6
CTMX · 23284F105
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Cybin Inc.
13G/A
Amendment 3
HELP · 23256X407
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Adicet Bio, Inc.
13G/A
Amendment 4
ACET · 007002207
|
0.1% |
2/17/2026
Event 12/31/2025
|
|||
| Tang Capital Management, LLC | 0.1% | ||||
| Kevin Tang | 0.1% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0.1% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Capricor Therapeutics, Inc.
13G
CAPR · 14070B309
|
6.6% |
1/26/2026
Event 1/16/2026
|
|||
| Tang Capital Management, LLC | 6.6% | ||||
| Kevin Tang | 6.6% | ||||
| Tang Capital Partners, LP | 4.5% | ||||
| Tang Capital Partners International, LP | 2.1% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ESSA Pharma Inc.
13G/A
Amendment 1
EPIX · 29668H708
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Compass Therapeutics, Inc.
13G/A
Amendment 3
CMPX · 20454B104
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 10.0% | ||||
| Kevin Tang | 10.0% | ||||
| Tang Capital Partners, LP | 6.0% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 0.6% | ||||
| Tang Capital Partners IV, Inc | 0.2% | ||||
|
Bolt Biotherapeutics, Inc.
13G/A
Amendment 4
BOLT · 097702203
|
3.5% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 3.5% | ||||
| Kevin Tang | 3.5% | ||||
| Tang Capital Partners, LP | 2.0% | ||||
| Tang Capital Partners International, LP | 1.5% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ALX Oncology Holdings Inc.
13G/A
Amendment 3
ALXO · 00166B105
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ESSA Pharma Inc.
13G/A
Amendment 1
EPIX · 29668H708
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Compass Therapeutics, Inc.
13G/A
Amendment 3
CMPX · 20454B104
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 10.0% | ||||
| Kevin Tang | 10.0% | ||||
| Tang Capital Partners, LP | 6.0% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 0.6% | ||||
| Tang Capital Partners IV, Inc | 0.2% | ||||
|
Bolt Biotherapeutics, Inc.
13G/A
Amendment 4
BOLT · 097702203
|
3.5% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 3.5% | ||||
| Kevin Tang | 3.5% | ||||
| Tang Capital Partners, LP | 2.0% | ||||
| Tang Capital Partners International, LP | 1.5% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ALX Oncology Holdings Inc.
13G/A
Amendment 3
ALXO · 00166B105
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Galapagos NV
13G
LKFT · 36315X101
|
8.4% |
10/29/2025
Event 10/27/2025
|
|||
| Tang Capital Management, LLC | 8.4% | ||||
| Kevin Tang | 8.4% | ||||
| Tang Capital Partners, LP | 5.0% | ||||
| Tang Capital Partners International, LP | 3.4% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Immunocore Holdings plc
13G
IMCR · 45258D105
|
5.2% |
10/24/2025
Event 10/17/2025
|
|||
| Tang Capital Management, LLC | 5.2% | ||||
| Kevin Tang | 5.2% | ||||
| Tang Capital Partners, LP | 3.2% | ||||
| Tang Capital Partners International, LP | 2.0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Keros Therapeutics, Inc.
13G
KROS · 492327101
|
7.9% |
10/22/2025
Event 10/15/2025
|
|||
| Tang Capital Management, LLC | 7.9% | ||||
| Kevin Tang | 7.9% | ||||
| Tang Capital Partners, LP | 5.2% | ||||
| Tang Capital Partners International, LP | 2.7% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Crescent Biopharma, Inc.
13G
CBIO · G2545C104
|
5.0% |
10/9/2025
Event 10/2/2025
|
|||
| Tang Capital Management, LLC | 5.0% | ||||
| Kevin Tang | 5.0% | ||||
| Tang Capital Partners, LP | 2.8% | ||||
| Tang Capital Partners International, LP | 2.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
PMV Pharmaceuticals, Inc.
13G
PMVP · 69353Y103
|
8.9% |
9/23/2025
Event 9/16/2025
|
|||
| Tang Capital Management, LLC | 8.9% | ||||
| Kevin Tang | 8.9% | ||||
| Tang Capital Partners, LP | 5.0% | ||||
| Tang Capital Partners International, LP | 3.9% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
HilleVax, Inc.
13D/A
Amendment 1
HLVX · 43157M102
|
0% |
9/19/2025
Event 9/17/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
ITeos Therapeutics, Inc.
13D/A
Amendment 2
ITOS · 46565G104
|
100.0% |
9/3/2025
Event 8/29/2025
|
|||
| Tang Capital Management, LLC | 100.0% | ||||
| Kevin Tang | 100.0% | ||||
| Tang Capital Partners, LP | 100.0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 100.0% | ||||
| Concentra Merger Sub VIII, Inc | 0% | ||||
|
Cargo Therapeutics, Inc.
13D/A
Amendment 2
CRGX · 14179K101
|
100.0% |
8/21/2025
Event 8/19/2025
|
|||
| Tang Capital Management, LLC | 100.0% | ||||
| Kevin Tang | 100.0% | ||||
| Tang Capital Partners, LP | 100.0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 100.0% | ||||
| Concentra Merger Sub VII, Inc. | 0% | ||||
|
Reviva Pharmaceuticals Holdings, Inc.
13G/A
Amendment 4
RVPH · 76152G100
|
4.8% |
8/14/2025
Event 6/30/2025
|
|||
| Tang Capital Management, LLC | 4.8% | ||||
| Kevin Tang | 4.8% | ||||
| Tang Capital Partners, LP | 4.8% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Outlook Therapeutics, Inc.
13G/A
Amendment 3
OTLK · 69012T305
|
3.4% |
8/14/2025
Event 6/30/2025
|
|||
| Tang Capital Management, LLC | 3.4% | ||||
| Kevin Tang | 3.4% | ||||
| Tang Capital Partners, LP | 3.4% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Elevation Oncology, Inc.
13G/A
Amendment 3
ELEV · 28623U101
|
4.99% |
8/14/2025
Event 6/30/2025
|
|||
| Tang Capital Management, LLC | 4.99% | ||||
| Kevin Tang | 4.99% | ||||
| Tang Capital Partners, LP | 4.99% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 5
CTMX · 23284F105
|
7.0% |
8/14/2025
Event 6/30/2025
|
|||
| Tang Capital Management, LLC | 7.0% | ||||
| Kevin Tang | 7.0% | ||||
| Tang Capital Partners, LP | 4.7% | ||||
| Tang Capital Partners International, LP | 2.3% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Compass Therapeutics, Inc.
13G/A
Amendment 2
CMPX · 20454B104
|
9.8% |
8/14/2025
Event 6/30/2025
|
|||
| Tang Capital Management, LLC | 9.8% | ||||
| Kevin Tang | 9.8% | ||||
| Tang Capital Partners, LP | 4.9% | ||||
| Tang Capital Partners International, LP | 3.9% | ||||
| Tang Capital Partners III, Inc | 0.7% | ||||
| Tang Capital Partners IV, Inc | 0.3% | ||||
|
Bolt Biotherapeutics, Inc.
13G/A
Amendment 3
BOLT · 097702203
|
8.7% |
8/14/2025
Event 6/30/2025
|
|||
| Tang Capital Management, LLC | 8.7% | ||||
| Kevin Tang | 8.7% | ||||
| Tang Capital Partners, LP | 4.9% | ||||
| Tang Capital Partners International, LP | 3.8% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ESSA Pharma Inc.
13G
EPIX · 29668H708
|
9.7% |
7/30/2025
Event 7/30/2025
|
|||
| Tang Capital Management, LLC | 9.7% | ||||
| Kevin Tang | 9.7% | ||||
| Tang Capital Partners, LP | 5.5% | ||||
| Tang Capital Partners International, LP | 4.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
ITeos Therapeutics, Inc.
13D/A
Amendment 1
ITOS · 46565G104
|
10.0% |
7/22/2025
Event 7/18/2025
|
|||
| Tang Capital Management, LLC | 10.0% | ||||
| Kevin Tang | 10.0% | ||||
| Tang Capital Partners, LP | 6.8% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Cargo Therapeutics, Inc.
13D/A
Amendment 1
CRGX · 14179K101
|
6.6% |
7/9/2025
Event 7/7/2025
|
|||
| Tang Capital Management, LLC | 6.6% | ||||
| Kevin Tang | 6.6% | ||||
| Tang Capital Partners, LP | 3.7% | ||||
| Tang Capital Partners International, LP | 2.9% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
ITeos Therapeutics, Inc.
13D
ITOS · 46565G104
|
10.0% |
6/12/2025
Event 6/11/2025
|
|||
| Tang Capital Management, LLC | 10.0% | ||||
| Kevin Tang | 10.0% | ||||
| Tang Capital Partners, LP | 6.8% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Acelyrin, Inc.
13D/A
Amendment 3
SLRN · 00445A100
|
0% |
5/23/2025
Event 5/21/2025
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Allakos Inc.
13D/A
Amendment 3
ALLK · 01671P100
|
100.0% |
5/19/2025
Event 5/15/2025
|
|||
| Tang Capital Management, LLC | 100.0% | ||||
| Kevin Tang | 100.0% | ||||
| Tang Capital Partners, LP | 100.0% | ||||
| Tang Capital Partners International, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 100.0% | ||||
| Concentra Merger Sub III, Inc | 0% | ||||
|
Tarsus Pharmaceuticals, Inc.
13G/A
Amendment 3
TARS · 87650L103
|
5.9% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 5.9% | ||||
| Kevin Tang | 5.9% | ||||
| Tang Capital Partners, LP | 5.6% | ||||
| Tang Capital Partners International, LP | 0.2% | ||||
| Tang Capital Partners III, Inc | 0.1% | ||||
| Tang Capital Partners IV, Inc | <0.1% | ||||
|
Reviva Pharmaceuticals Holdings, Inc.
13G/A
Amendment 3
RVPH · 76152G100
|
7.8% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 7.8% | ||||
| Kevin Tang | 7.8% | ||||
| Tang Capital Partners, LP | 7.3% | ||||
| Tang Capital Partners International, LP | 0.5% | ||||
| Tang Capital Partners III, Inc | 0.1% | ||||
| Tang Capital Partners IV, Inc | <0.1% | ||||
|
Precision BioSciences, Inc.
13G/A
Amendment 2
DTIL · 74019P207
|
6.4% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 6.4% | ||||
| Kevin Tang | 6.4% | ||||
| Tang Capital Partners, LP | 3.6% | ||||
| Tang Capital Partners International, LP | 2.8% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Outlook Therapeutics, Inc.
13G/A
Amendment 2
OTLK · 69012T305
|
5.6% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 5.6% | ||||
| Kevin Tang | 5.6% | ||||
| Tang Capital Partners, LP | 4.9% | ||||
| Tang Capital Partners International, LP | 0.3% | ||||
| Tang Capital Partners III, Inc | 0.4% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
KalVista Pharmaceuticals, Inc.
13G/A
Amendment 4
KALV · 483497103
|
9.9% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 9.9% | ||||
| Kevin Tang | 9.9% | ||||
| Tang Capital Partners, LP | 6.6% | ||||
| Tang Capital Partners International, LP | 1.4% | ||||
| Tang Capital Partners III, Inc | 1.7% | ||||
| Tang Capital Partners IV, Inc | 0.2% | ||||
|
Journey Medical Corporation
13G/A
Amendment 1
DERM · 48115J109
|
8.0% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 8.0% | ||||
| Kevin Tang | 8.0% | ||||
| Tang Capital Partners, LP | 4.6% | ||||
| Tang Capital Partners International, LP | 3.4% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ITeos Therapeutics, Inc.
13G
ITOS · 46565G104
|
10.0% |
5/15/2025
Event 5/13/2025
|
|||
| Tang Capital Management, LLC | 10.0% | ||||
| Kevin Tang | 10.0% | ||||
| Tang Capital Partners, LP | 6.8% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Evolus, Inc.
13G/A
Amendment 3
EOLS · 30052C107
|
7.9% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 7.9% | ||||
| Kevin Tang | 7.9% | ||||
| Tang Capital Partners, LP | 5.5% | ||||
| Tang Capital Partners International, LP | 1.3% | ||||
| Tang Capital Partners III, Inc | 1.0% | ||||
| Tang Capital Partners IV, Inc | 0.1% | ||||
|
Elevation Oncology, Inc.
13G/A
Amendment 2
ELEV · 28623U101
|
10.0% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 10.0% | ||||
| Kevin Tang | 10.0% | ||||
| Tang Capital Partners, LP | 8.4% | ||||
| Tang Capital Partners International, LP | 0.9% | ||||
| Tang Capital Partners III, Inc | 0.7% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 4
CTMX · 23284F105
|
8.4% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 8.4% | ||||
| Kevin Tang | 8.4% | ||||
| Tang Capital Partners, LP | 6.2% | ||||
| Tang Capital Partners International, LP | 2.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Cybin Inc.
13G/A
Amendment 2
HELP · 23256X407
|
9.1% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 9.1% | ||||
| Kevin Tang | 9.1% | ||||
| Tang Capital Partners, LP | 6.2% | ||||
| Tang Capital Partners International, LP | 2.9% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Compass Therapeutics, Inc.
13G/A
Amendment 1
CMPX · 20454B104
|
8.0% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 8.0% | ||||
| Kevin Tang | 8.0% | ||||
| Tang Capital Partners, LP | 4.0% | ||||
| Tang Capital Partners International, LP | 3.1% | ||||
| Tang Capital Partners III, Inc | 0.7% | ||||
| Tang Capital Partners IV, Inc | 0.2% | ||||
|
Bolt Biotherapeutics, Inc.
13G/A
Amendment 2
BOLT · 097702104
|
9.9% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 9.9% | ||||
| Kevin Tang | 9.9% | ||||
| Tang Capital Partners, LP | 5.6% | ||||
| Tang Capital Partners International, LP | 4.3% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ALX Oncology Holdings Inc.
13G/A
Amendment 2
ALXO · 00166B105
|
5.9% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 5.9% | ||||
| Kevin Tang | 5.9% | ||||
| Tang Capital Partners, LP | 3.2% | ||||
| Tang Capital Partners International, LP | 2.7% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Adicet Bio, Inc.
13G/A
Amendment 3
ACET · 007002108
|
9.9% |
5/15/2025
Event 3/31/2025
|
|||
| Tang Capital Management, LLC | 9.9% | ||||
| Kevin Tang | 9.9% | ||||
| Tang Capital Partners, LP | 5.7% | ||||
| Tang Capital Partners International, LP | 4.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
HilleVax, Inc.
13D
HLVX · 43157M102
|
9.8% |
5/2/2025
Event 5/2/2025
|
|||
| Tang Capital Management, LLC | 9.8% | ||||
| Kevin Tang | 9.8% | ||||
| Tang Capital Partners, LP | 5.5% | ||||
| Tang Capital Partners International, LP | 4.3% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Spyre Therapeutics, Inc.
13G
SYRE · 00773J202
|
5.3% |
5/1/2025
Event 4/24/2025
|
|||
| Tang Capital Management, LLC | 5.3% | ||||
| Kevin Tang | 5.3% | ||||
| Tang Capital Partners, LP | 3.0% | ||||
| Tang Capital Partners International, LP | 2.3% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Allakos Inc.
13D/A
Amendment 2
ALLK · 01671P100
|
9.6% |
4/17/2025
Event 4/15/2025
|
|||
| Tang Capital Management, LLC | 9.6% | ||||
| Kevin Tang | 9.6% | ||||
| Tang Capital Partners, LP | 5.4% | ||||
| Tang Capital Partners International, LP | 4.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
| Concentra Merger Sub III, Inc | 0% | ||||
|
Kiniksa Pharmaceuticals International, plc
13G
KNSA · G52694109
|
5.2% |
4/4/2025
Event 3/28/2025
|
|||
| Tang Capital Management, LLC | 5.2% | ||||
| Kevin Tang | 5.2% | ||||
| Tang Capital Partners, LP | 2.5% | ||||
| Tang Capital Partners International, LP | 2.3% | ||||
| Tang Capital Partners III, Inc | 0.3% | ||||
| Tang Capital Partners IV, Inc | 0.1% | ||||
|
Allakos Inc.
13D/A
Amendment 1
ALLK · 01671P100
|
9.6% |
4/3/2025
Event 4/1/2025
|
|||
| Tang Capital Management, LLC | 9.6% | ||||
| Kevin Tang | 9.6% | ||||
| Tang Capital Partners, LP | 5.4% | ||||
| Tang Capital Partners International, LP | 4.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Acelyrin, Inc.
13D/A
Amendment 2
SLRN · 00445A100
|
8.8% |
3/12/2025
Event 3/10/2025
|
|||
| Tang Capital Management, LLC | 8.8% | ||||
| Kevin Tang | 8.8% | ||||
| Tang Capital Partners, LP | 5.0% | ||||
| Tang Capital Partners International, LP | 3.8% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Pliant Therapeutics, Inc.
13D
PLRX · 729139105
|
9.6% |
3/10/2025
Event 3/3/2025
|
|||
| Tang Capital Management, LLC | 9.6% | ||||
| Kevin Tang | 9.6% | ||||
| Tang Capital Partners, LP | 5.4% | ||||
| Tang Capital Partners International, LP | 4.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Aurinia Pharmaceuticals Inc.
13D/A
Amendment 1
AUPH · 05156V102
|
7.3% |
3/4/2025
Event 2/28/2025
|
|||
| Tang Capital Management, LLC | 7.3% | ||||
| Kevin Tang | 7.3% | ||||
| Tang Capital Partners, LP | 3.7% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 0.4% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Acelyrin, Inc.
13D/A
Amendment 1
SLRN · 00445A100
|
7.3% |
2/27/2025
Event 2/25/2025
|
|||
| Tang Capital Management, LLC | 7.3% | ||||
| Kevin Tang | 7.3% | ||||
| Tang Capital Partners, LP | 4.1% | ||||
| Tang Capital Partners International, LP | 3.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
CARGO Therapeutics, Inc.
13D
CRGX · 14179K101
|
5.9% |
2/21/2025
Event 2/13/2025
|
|||
| Tang Capital Management, LLC | 5.9% | ||||
| Kevin Tang | 5.9% | ||||
| Tang Capital Partners, LP | 3.3% | ||||
| Tang Capital Partners International, LP | 2.6% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Acelyrin, Inc.
13D
SLRN · 00445A100
|
5.3% |
2/20/2025
Event 2/18/2025
|
|||
| Tang Capital Management, LLC | 5.3% | ||||
| Kevin Tang | 5.3% | ||||
| Tang Capital Partners, LP | 3.0% | ||||
| Tang Capital Partners International, LP | 2.3% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Galapagos NV
13D
LKFT · 36315X101
|
7.5% |
2/14/2025
Event 2/7/2025
|
|||
| Tang Capital Management, LLC | 7.5% | ||||
| Kevin Tang | 7.5% | ||||
| Tang Capital Partners, LP | 4.2% | ||||
| Tang Capital Partners International, LP | 3.0% | ||||
| Tang Capital Partners III, Inc | 0.3% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Monopar Therapeutics Inc.
13G/A
Amendment 1
MNPR · 61023L207
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Tang Capital Management, LLC | 0% | ||||
| Kevin Tang | 0% | ||||
| Tang Capital Partners, LP | 0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
ITeos Therapeutics, Inc.
13G/A
Amendment 1
ITOS · 46565G104
|
0.6% |
2/14/2025
Event 12/31/2024
|
|||
| Tang Capital Management, LLC | 0.6% | ||||
| Kevin Tang | 0.6% | ||||
| Tang Capital Partners, LP | 0.6% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Cybin Inc.
13G/A
Amendment 1
HELP · 23256X407
|
6.7% |
2/14/2025
Event 12/31/2024
|
|||
| Tang Capital Management, LLC | 6.7% | ||||
| Kevin Tang | 6.7% | ||||
| Tang Capital Partners, LP | 6.7% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Allakos Inc.
13D
ALLK · 01671P100
|
9.7% |
2/3/2025
Event 1/27/2025
|
|||
| Tang Capital Management, LLC | 9.7% | ||||
| Kevin Tang | 9.7% | ||||
| Tang Capital Partners, LP | 5.5% | ||||
| Tang Capital Partners International, LP | 4.2% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
| Concentra Biosciences, LLC | 0% | ||||
|
Nkarta, Inc.
13G
NKTX · 65487U108
|
9.9% |
1/27/2025
Event 1/17/2025
|
|||
| Tang Capital Management, LLC | 9.9% | ||||
| Kevin Tang | 9.9% | ||||
| Tang Capital Partners, LP | 7.9% | ||||
| Tang Capital Partners International, LP | 2.0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||
|
Compass Therapeutics, Inc.
13G
CMPX · 20454B104
|
5.4% |
1/16/2025
Event 1/8/2025
|
|||
| Tang Capital Management, LLC | 5.4% | ||||
| Kevin Tang | 5.4% | ||||
| Tang Capital Partners, LP | 3.4% | ||||
| Tang Capital Partners International, LP | 2.0% | ||||
| Tang Capital Partners III, Inc | 0% | ||||
| Tang Capital Partners IV, Inc | 0% | ||||